Clinical Trials - LBRX

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06179108Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaCOMPLETEDPHASE22023-11-292024-12-042024-12-04
NCT04588129Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy VolunteersCOMPLETEDPHASE12021-01-052021-11-152021-09-17
NCT04187560Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy AdultsCOMPLETEDPHASE12020-01-222020-11-092020-07-01